Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Aktionärsstruktur

Inhaber in %
Freefloat 99.39
PRIMECAP Management Co. 11.06
PRIMECAP Management Co. 10.88
Vanguard Group, Inc. (Subfiler) 8.00
The Vanguard Group, Inc. 7.97
Vanguard PRIMECAP Fund 6.23
State Street Corp. 4.74
Wellington Management Co. LLP 3.71
BlackRock Fund Advisors 3.43
T. Rowe Price Investment Management, Inc. 3.28
Vanguard Health Care Fund 3.15
Vanguard Total Stock Market ETF 3.13
Vanguard 500 Index Fund 2.42
JPMorgan Investment Management, Inc. 2.41
Geode Capital Management LLC 2.24

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2018 2019 2020 2021 2022
Personal am Ende des Jahres 7'800 7'400 9'100 9'610 8'725
Umsatz pro Mitarbeiter in Mio. EUR 1.55 1.72 1.36 1.08 1.08

Bilanz (in Mio. EUR) - Aktiva

2018 2019 2020 2021 2022
Summe Umlaufvermögen 7'641 8'382 6'887 7'857 9'791
Summe Anlagevermögen 18'976 19'784 18'612 18'589 20'109
Summe Aktiva 25'289 27'234 24'619 23'877 24'554

Bilanz (in Mio. EUR) - Passiva

2018 2019 2020 2021 2022
Gesamtverschuldung/ -verbindlichkeiten 5'937 6'441 7'911 7'693 6'711
Summe Fremdkapital 12'257 13'895 13'933 12'918 11'166
Summe Eigenkapital 13'032 13'339 10'686 10'960 13'388
Summe Passiva 25'289 27'234 24'619 23'877 24'554

Adresse

225 Binney Street, 02142 Cambridge
Telefon +1 (617) 679-2000
URL http://www.biogen.com

Management

Adam Keeney
Executive VP & Head-Corporate Development
Anabella Villalobos
SVP-Biotherapeutic & Medicinal Sciences
Ann E. Beasley
Chief Compliance Officer & Senior Vice President
Caroline D. Dorsa
Chairman
Christopher A. Viehbacher
President, Chief Executive Officer & Director
Chuck Triano
Senior Vice President
Eric K. Rowinsky
Independent Director
Ginger Gregory
Chief Human Resources Officer & Executive VP
Jake Elkins
Vice President & Head-Acute Neurology Research
Jane Grogan
Executive Vice President & Head-Research
Jesus B. Mantas
Independent Director
Mahalakshmi Radhakrishnan
Chief Medical Officer & Group Senior VP
Maria C. Freire
Independent Director
Michael E. Dambach
Treasurer & Vice President
Michael Hencke
Executive Director-Investor Relations
Michael R. McDonnell
Chief Financial Officer & Executive Vice President
Nicole Murphy
Head-Pharmaceutical Operations & Technology
Priya Singhal
Executive Vice President & Head-Development
Rachid Izzar
Executive Vice President
Robert Kilo
Account Director
Robin C. Kramer
Chief Accounting Officer & Senior Vice President
Rohin Mhatre
Senior VP-Product & Technology Development
Stephen A. Sherwin
Independent Director
Susan H. Alexander
Secretary, Chief Legal Officer & Executive VP
Susan Langer
Independent Director
Wendell C. Taylor
Chief Corporation Counsel & Assistant Secretary
William A. Hawkins
Independent Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen